Active Eradication of Helicobacter pylori Within Organized Massive Screening Might Improve Survival of Gastric Cancer Patients

Gastroenterology. 2023 Jan;164(1):162-163. doi: 10.1053/j.gastro.2022.05.009. Epub 2022 May 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Early Detection of Cancer
  • Gastric Mucosa
  • Helicobacter Infections* / diagnosis
  • Helicobacter Infections* / drug therapy
  • Helicobacter pylori*
  • Humans
  • Risk Factors
  • Stomach Neoplasms* / prevention & control

Substances

  • Anti-Bacterial Agents